Prescriptions of GLP-1RA have surged by 300% from 2020 to 2022, reaching 9 million annually [10], reflecting the high prevalence of T2D (15%) and obesity (42%) among U.S
The most common side effects of GLP-1 are gastrointestinal issues, and some foods may be more likely to increase nausea and stomach discomfort than others while using these meds
Vitamin B5 25mg
Wagner KR, Abdel-Hamid HZ, Mah JK, Campbell C, Guglieri M, Muntoni F et al (2020) Randomized phase 2 trial and open-label extension of Domagrozumab in Duchenne muscular dystrophy
GLP-1 therapies may also increase the risk of pancreatitis, although this concern seems to have abated in the last 2 years [36,37,38,39]